Jul 30, 2026 06:30AM
Jul 22, 2026 06:51AM
Jul 21, 2026 07:00AM
Jul 21, 2026 07:00AM
Jul 7, 2026 07:00AM
Jul 7, 2026 07:00AM
Dec 26, 2025 07:01AM Agios Pharma (AGIO) PT Raised to $34 at BofA Securities
Dec 9, 2025 06:56AM
Dec 8, 2025 07:02AM
Dec 8, 2025 07:00AM
Nov 24, 2025 07:36AM
Nov 20, 2025 07:51AM
Nov 20, 2025 06:19AM
Nov 19, 2025 01:53PM Agios Pharma (AGIO) PT Lowered to $32 at BofA Securities
Nov 19, 2025 12:44PM
Oct 30, 2025 06:30AM
Oct 20, 2025 06:42AM
Oct 17, 2025 08:01AM
Oct 17, 2025 08:00AM
Sep 5, 2025 06:44AM
Sep 5, 2025 05:02AM Goldman Sachs on Agios Pharma (AGIO): 'we see a favorable risk-benefit profile'
Sep 4, 2025 12:08PM
Sep 4, 2025 10:23AM
Sep 4, 2025 07:00AM
Sep 4, 2025 07:00AM
Aug 5, 2025 06:34AM
Aug 4, 2025 04:01PM
Aug 4, 2025 04:01PM Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia
Jul 31, 2025 06:30AM
Jun 16, 2025 09:36AM
Jun 10, 2025 06:37AM
May 2, 2025 07:12AM
May 1, 2025 06:30AM
Feb 24, 2025 06:21AM
Feb 13, 2025 06:31AM Agios Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
Jan 13, 2025 12:50PM
Jan 13, 2025 07:00AM
Jan 8, 2025 07:02AM
Jan 8, 2025 07:00AM
Aug 2, 2024 06:21AM
Aug 1, 2024 06:31AM
May 28, 2024 10:46AM Piper Sandler Reiterates Overweight Rating on Agios Pharma (AGIO)
May 28, 2024 07:10AM
May 28, 2024 07:00AM
May 28, 2024 07:00AM
May 3, 2024 06:34AM
May 2, 2024 07:00AM
Dec 3, 2021 09:00AM
Nov 3, 2021 07:10AM Agios Reports Business Highlights and Third Quarter 2021 Financial Results
Aug 17, 2021 04:01PM

15,661 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All